Participants in this study who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes for liver cancer, and participants with longer exposure to statins ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC) and hepatic decompensation among patients with chronic liver disease (CLD ...